These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 25788956)

  • 81. Evolution of precore/core promoter mutations in hepatitis B carriers with hepatitis B e antigen seroreversion.
    Liu CJ; Chen PJ; Lai MY; Kao JH; Chen DS
    J Med Virol; 2004 Oct; 74(2):237-45. PubMed ID: 15332272
    [TBL] [Abstract][Full Text] [Related]  

  • 82. High level of hepatitis B virus DNA after HBeAg-to-anti-HBe seroconversion is related to coexistence of mutations in its precore and basal core promoter.
    Peng XM; Huang GM; Li JG; Huang YS; Mei YY; Gao ZL
    World J Gastroenterol; 2005 May; 11(20):3131-4. PubMed ID: 15918203
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Precise analysis of the effect of basal core promoter/precore mutations on the main phenotype of chronic hepatitis B in mouse models.
    Liu Y; Zhao ZH; Lv XQ; Tang YW; Cao M; Xiang Q; Wu Y; Zhang HT; Lai GQ
    J Med Virol; 2020 Dec; 92(12):3412-3419. PubMed ID: 32427358
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Association of core promoter mutations with viral breakthrough in chronic hepatitis B patients on long-term lamivudine therapy.
    Kazim SN; Chauhan R; Das BC; Sarin SK
    J Gastroenterol Hepatol; 2006 Oct; 21(10):1525-32. PubMed ID: 16928212
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Molecular Characterization of Pre-Core/Core and S Region of Hepatitis B Virus in Hemodialysis Patients With Occult Hepatitis B Infection.
    Rastegarvand N; Makvandi M; Samarbafzadeh A; Rasti M; Neisi N; Pouremamali A; Teimoori A; Shabani A
    Jundishapur J Microbiol; 2015 Oct; 8(10):e23686. PubMed ID: 26587212
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Correlation between viral load of HBV in chronic hepatitis B patients and precore and Basal core promoter mutations.
    Ghabeshi S; Sharifi Z; Hosseini SM; Mahmoodian Shooshtari M
    Hepat Mon; 2013 Feb; 13(2):e7415. PubMed ID: 23599717
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Prevalence and Characteristics of Basal Core Promoter Mutations in Iran and its Correlation with Acute and Chronic Hepatitis B Infection.
    Nasrollaheian S; Farshidfar G; Kheirabad AK; Gouklani H
    Electron Physician; 2016 Dec; 8(12):3462-3467. PubMed ID: 28163866
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Cohort profile: golestan hepatitis B cohort study- a prospective long term study in northern iran ​.
    Poustchi H; Katoonizadeh A; Ostovaneh MR; Moossavi S; Sharafkhah M; Esmaili S; Pourshams A; Mohamadkhani A; Besharat S; Merat S; Mohamadnejad M; George J; Malekzadeh R
    Middle East J Dig Dis; 2014 Oct; 6(4):186-94. PubMed ID: 25349681
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Frequency and distribution of hepatitis B virus genotypes among eastern Indian voluntary blood donors: Association with precore and basal core promoter mutations.
    Biswas A; Chandra PK; Datta S; Panigrahi R; Banerjee A; Chakrabarti S; Biswas K; Patra D; Bhattacharya P; Biswas K; Chakravarty R
    Hepatol Res; 2009 Jan; 39(1):53-9. PubMed ID: 18713275
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Prevalence and clinical significance of hepatitis B Basal core promoter and precore gene mutations in southern Iranian patients.
    Taghavi SA; Tabibi M; Eshraghian A; Keyvani H; Eshraghian H
    Hepat Mon; 2010; 10(4):294-7. PubMed ID: 22312396
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Serological and molecular characterization of hepatitis B virus in asymptomatic blood donors in Iran.
    Attaran MS; Hosseini SM; Fakhari J; Sharifi Z
    Iran J Microbiol; 2018 Feb; 10(1):59-64. PubMed ID: 29922420
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Qidong hepatitis B virus infection cohort: a 25-year prospective study in high risk area of primary liver cancer.
    Chen T; Qian G; Fan C; Sun Y; Wang J; Lu P; Xue X; Wu Y; Zhang Q; Jin Y; Wu Y; Gan Y; Lu J; Kensler TW; Groopman JD; Tu H
    Hepatoma Res; 2018; 4():. PubMed ID: 29479565
    [TBL] [Abstract][Full Text] [Related]  

  • 93. HBV with precore and basal core promoter mutations exhibits a high replication phenotype and causes ER stress-mediated cell death in humanized liver chimeric mice.
    Uchida T; Imamura M; Hayes CN; Suehiro Y; Teraoka Y; Ohya K; Aikata H; Abe-Chayama H; Ishida Y; Tateno C; Hara Y; Hino K; Okamoto T; Matsuura Y; Aizaki H; Wake K; Kohara M; Liang TJ; Oka S; Chayama K
    Hepatology; 2023 Sep; 78(3):929-942. PubMed ID: 36896966
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Influencing Factors on the Outcome and Prognosis of Patients With HBV Infction: Seven Years Follow-up.
    Sali S; Alavian SM; Foster GR; Keyvani H; Mehrnoosh L; Mohammadi N
    Hepat Mon; 2013; 13(7):e8743. PubMed ID: 24066002
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Pathological changes of liver one year later in CHB patients with negative HBV DNA.
    Shanshan W; Xinfang D; Shuihong Y; Kecong L; Jinjin Q; Zhi C; Feng C
    Infect Agent Cancer; 2019; 14():48. PubMed ID: 31827599
    [TBL] [Abstract][Full Text] [Related]  

  • 96. The Possible Role of TLR2 in Chronic Hepatitis B Patients with Precore Mutation.
    Moradzadeh M; Tayebi S; Poustchi H; Sayehmiri K; Shahnazari P; Naderi E; Montazeri G; Mohamadkhani A
    Adv Virol; 2013; 2013():780319. PubMed ID: 24187552
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Association of hepatitis B genotypes with clinical profile of patients with chronic hepatitis B.
    Baclig MO; Reyes KG; Liles VR; Gopez-Cervantes J
    Int J Mol Epidemiol Genet; 2020; 11(2):26-30. PubMed ID: 33240460
    [TBL] [Abstract][Full Text] [Related]  

  • 98. The importance of hepatitis B virus genome diversity in Basal core promoter region.
    Mohamadkhani A; Montazeri G; Poustchi H
    Middle East J Dig Dis; 2011 Mar; 3(1):13-9. PubMed ID: 25197527
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Pre-S1 Mutations as Indicated by Serum Pre-S1 Antigen Negative is Associated with an Increased Risk of Hepatocellular Carcinoma in Chronic Hepatitis B Patients.
    Zhang X; Gu C; Wei Q; Cao Y; She W; Shi H; Xie Y; Guo J
    J Hepatocell Carcinoma; 2023; 10():599-609. PubMed ID: 37069959
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Hepatitis B virus DNA level Among the Seropositive Afghan Immigrants, Southern Iran.
    Behzadi MA; Ziyaeyan M; Asaei S
    Jundishapur J Microbiol; 2014 May; 7(5):e10127. PubMed ID: 25147713
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.